Structures by: Butcher R. J.
Total: 1 152
{Tris[2-(imidazol-2-ylmethylimino)ethyl]methylammonium}iron(II) tris(perchlorate) dihydrate
C19H27FeN103,3(ClO4),2(H2O)
Acta Crystallographica Section E (2008) 64, 1 m1-m1
a=13.9630(18)Å b=11.7810(15)Å c=37.182(5)Å
α=90° β=90° γ=90°
[(6-Methyl-2-pyridylmethyl)(2-pyridylmethyl)amine][(2- pyridylmethyl)amine]copper(II) bis(perchlorate)
C19H23CuN52,2ClO4
Acta Crystallographica Section E (2008) 64, 1 m74-m75
a=9.3178(10)Å b=13.9691(19)Å c=19.223(3)Å
α=90° β=99.931(11)° γ=90°
Β-Arteether
C17H28O5
Acta Crystallographica Section E (2008) 64, 3 o585-o586
a=10.0253(6)Å b=10.0253(6)Å c=28.628(3)Å
α=90.00° β=90.00° γ=120.00°
2,6--Diphenyl--piperidine
C27H24N2O
Acta Crystallographica Section E (2008) 64, 5 o797
a=9.4034(17)Å b=10.646(6)Å c=10.8860(18)Å
α=90.45(2)° β=99.957(14)° γ=101.98(3)°
5,6-Dioxo-1,10-phenanthrolin-1-ium trifluoromethanesulfonate
C12H7N2O2,CF3O3S
Acta Crystallographica Section E (2008) 64, 8 o1543
a=6.4896(2)Å b=16.3963(5)Å c=13.2430(3)Å
α=90.00° β=94.393(2)° γ=90.00°
Carbazol derivative
C12H10ClNO
Acta Crystallographica Section E (2008) 64, 8 o1635
a=10.4211(5)Å b=5.6851(3)Å c=17.0824(10)Å
α=90° β=100.239(6)° γ=90°
Chalcone
C16H13FOS
Acta Crystallographica Section E (2008) 64, 11 o2118-o2119
a=29.7846(9)Å b=5.7070(3)Å c=7.7071(4)Å
α=90° β=90.781(3)° γ=90°
(1<i>RS</i>,2<i>SR</i>,3<i>SR</i>,4<i>RS</i>,5<i>RS</i>)-3,5-Bis(4-fluorophenyl)-2,4-bis(pyridine-2-carbonyl)1-(pyridin-2-yl)cyclohexanol
C35H27F2N3O3
Acta Crystallographica Section C (2014) 70, 10 953-959
a=21.8864(9)Å b=11.2268(4)Å c=24.2670(9)Å
α=90° β=90° γ=90°
(1<i>RS</i>,2<i>SR</i>,3<i>SR</i>,4<i>RS</i>,5<i>RS</i>)- 3,5-Bis(4-bromophenyl)-2,4-bis(pyridine-2-carbonyl)-1-(pyridin-2-yl)cyclohexanol
C35H27Br2N3O3
Acta Crystallographica Section C (2014) 70, 10 953-959
a=9.5741(4)Å b=10.7061(3)Å c=15.9952(6)Å
α=92.863(3)° β=97.443(3)° γ=103.618(3)°
(1<i>RS</i>,2<i>SR</i>,3<i>SR</i>,4<i>RS</i>,5<i>RS</i>)-3,5-Bis(4-chlorophenyl)-2,4-bis(pyridine-2-carbonyl)-1-(pyridin-2-yl)cyclohexanol acetone 0.951-solvate
C35H27Cl2N3O3,0.951(C3H6O)
Acta Crystallographica Section C (2014) 70, 10 953-959
a=16.5446(6)Å b=53.4204(17)Å c=15.5857(4)Å
α=90° β=90° γ=90°
Acetoguanaminium hydrogen phthalate
C4H8N5,C8H5O4
Acta Crystallographica Section C (2010) 66, 7 o324-o328
a=7.0743(2)Å b=23.4468(5)Å c=8.11340(10)Å
α=90° β=107.0630(10)° γ=90°
Acetoguanaminium hydrogen maleate
C4H8N5,C4H3O4
Acta Crystallographica Section C (2010) 66, 7 o324-o328
a=7.1921(3)Å b=8.2359(3)Å c=9.4775(4)Å
α=98.287(2)° β=104.656(2)° γ=91.032(3)°
Acetoguanaminium 3-hydroxypicolinate monohydrate
C4H8N5,C6H4NO3,H2O
Acta Crystallographica Section C (2010) 66, 7 o324-o328
a=7.0397(16)Å b=24.680(5)Å c=7.5047(19)Å
α=90° β=94.462(7)° γ=90°
2-amino-4,6-dimethoxypyrimidinium picrate
C6H10N3O2,C6H2N3O7
Acta Crystallographica Section C (2009) 65, 2 o42-o45
a=8.8796(2)Å b=13.2847(3)Å c=14.1395(3)Å
α=99.8200(10)° β=100.7010(10)° γ=105.0950(10)°
Pyrimethaminium picrate dimethyl sulfoxide solvate
C12H14ClN4,C6H2N3O7,C2H6OS
Acta Crystallographica Section C (2009) 65, 2 o42-o45
a=9.3365(3)Å b=11.1245(3)Å c=13.1861(6)Å
α=83.779(3)° β=86.057(3)° γ=65.784(3)°
Dihydropyrimidine
C14H16N2O2S
Acta Crystallographica Section E (2009) 65, 12 o3036
a=12.0415(2)Å b=6.22190(10)Å c=18.0192(3)Å
α=90° β=100.9010(10)° γ=90°
Dihydropyrimidine
C13H13ClN2OS
Acta Crystallographica Section E (2009) 65, 12 o3068
a=7.2346(12)Å b=22.585(3)Å c=8.0941(15)Å
α=90° β=106.177(17)° γ=90°
Piperidin-4-one
C22H27NO
Acta Crystallographica Section E (2009) 65, 12 o3083
a=12.2318(5)Å b=5.5879(2)Å c=26.9977(10)Å
α=90° β=94.377(3)° γ=90°
Piperidin-4-one
C19H19Cl2NO
Acta Crystallographica Section E (2008) 64, 12 o2312
a=13.1627(5)Å b=22.4739(7)Å c=5.8794(2)Å
α=90° β=90° γ=90°
Methylcyclohepta[b]indole
C14H15NO
Acta Crystallographica Section E (2009) 65, 4 o698
a=9.6731(4)Å b=10.0924(5)Å c=11.8328(6)Å
α=90° β=103.397(5)° γ=90°
Pyrano[2,3-a]carbazol-2(11H)-one
C17H13NO2
Acta Crystallographica Section E (2009) 65, 4 o830
a=26.8502(4)Å b=6.82020(10)Å c=15.8265(3)Å
α=90° β=115.531(2)° γ=90°
2-[2-(2-Pyridyl)ethyl]isoindolinium perchlorate
C15H17N2,ClO4
Acta Crystallographica Section E (2009) 65, 9 o2175
a=7.7941(9)Å b=11.7032(19)Å c=16.850(3)Å
α=90.00° β=90.00° γ=90.00°
Bis(1,10-phenanthroline-5,6-dione-κ^2^<i>N</i>,<i>N</i>)silver(I) tetrafluoridoborate
C24H12AgN4O4,BF4
Acta Crystallographica Section E (2009) 65, 9 m1119-m1120
a=13.2249(6)Å b=12.0115(17)Å c=14.4338(7)Å
α=90.00° β=108.481(5)° γ=90.00°
2-(Dimethylaminomethyl)phenyl phenyl telluride
C15H17NTe
Acta Crystallographica Section E (2009) 65, 10 o2562-o2563
a=8.5736(3)Å b=13.2472(5)Å c=12.6719(4)Å
α=90.00° β=95.933(3)° γ=90.00°
(<i>E</i>)-2-[(2-Hydroxy-5-nitrophenyl)iminiomethyl]phenolate
C13H10N2O4
Acta Crystallographica Section E (2009) 65, 3 o490-o491
a=7.3949(3)Å b=9.1058(4)Å c=17.2734(6)Å
α=90.00° β=96.387(4)° γ=90.00°
Dihydropyrazine
C23H20N2
Acta Crystallographica Section E (2009) 65, 3 o546
a=10.4406(10)Å b=10.5753(7)Å c=11.0810(13)Å
α=93.439(8)° β=114.161(10)° γ=118.343(9)°
2-Bromo-<i>N</i>'-[(2<i>Z</i>)-butan-2-ylidene]-5-methoxybenzohydrazide
C12H15BrN2O2
Acta Crystallographica Section E (2009) 65, 11 o2968-o2969
a=8.09420(10)Å b=14.2475(2)Å c=11.2974(2)Å
α=90.00° β=91.1519(13)° γ=90.00°
<i>N</i>-[2-(2-Bromobenzylamino)phenyl]-<i>N</i>-butyl-formamide
C18H21BrN2O
Acta Crystallographica Section E (2009) 65, 11 o2826
a=8.7067(4)Å b=10.8208(6)Å c=19.7480(13)Å
α=87.180(5)° β=82.622(5)° γ=66.706(5)°
Thiopyran-4-one 1-oxide
C17H15ClO2S
Acta Crystallographica Section E (2008) 64, 12 o2367
a=11.5195(5)Å b=25.7589(12)Å c=5.2248(2)Å
α=90° β=90° γ=90°
5-{5-Chloro-3-[4-(methylsulfonyl)phenyl]-2-pyridyl}-2-methylpyridinium 2,4,6-trinitrophenolate
C18H16ClN2O2S,C6H2N3O7
Acta Crystallographica Section E (2011) 67, 1 o107-o108
a=9.02500(10)Å b=12.74960(10)Å c=21.8011(3)Å
α=90.00° β=98.1140(10)° γ=90.00°
Enrofloxacinium picrate
C19H23FN3O3,C6H2N3O7
Acta Crystallographica Section E (2011) 67, 2 o432-o433
a=7.2111(7)Å b=12.5766(7)Å c=16.2362(4)Å
α=105.556(2)° β=96.367(6)° γ=96.223(7)°
2-Chloro-3-(4-chlorobenzamido)-1,4-naphthoquinone
C17H9Cl2NO3
Acta Crystallographica Section E (2009) 65, 1 o64
a=5.6011(2)Å b=8.7237(3)Å c=29.7957(9)Å
α=90.00° β=93.504(3)° γ=90.00°
<i>N</i>-(3-Bromo-1,4-dioxo-1,4-dihydro-2-naphthyl)-2-chloro-N-(2- chlorobenzoyl)benzamide
C24H12BrCl2NO4
Acta Crystallographica Section E (2009) 65, 1 o24
a=12.8590(3)Å b=7.81260(10)Å c=21.9574(4)Å
α=90.00° β=106.272(2)° γ=90.00°
Dihydropyrimidine-2(1H)-thione
C13H13ClN2OS
Acta Crystallographica Section E (2009) 65, 3 o564-o565
a=7.2389(6)Å b=8.2304(7)Å c=12.9038(11)Å
α=73.366(7)° β=89.373(7)° γ=72.613(7)°
3-(2-Chloroethyl)-2-methyl-4<i>H</i>-pyrido[1,2-<i>a</i>]pyrimidin-4-one
C11H11ClN2O
Acta Crystallographica Section E (2009) 65, 8 o1987-o1988
a=4.2546(4)Å b=11.6274(10)Å c=20.604(2)Å
α=90.00° β=90.00° γ=90.00°
2-Amino-5-nitrophenyl 2-chlorophenyl ketone
C13H9ClN2O3
Acta Crystallographica Section E (2009) 65, 8 o1908-o1909
a=10.6120(3)Å b=11.3314(3)Å c=10.8456(3)Å
α=90.00° β=108.399(3)° γ=90.00°
(2<i>E</i>)-1-(4-fluorophenyl)-3-(3,4,5-trimethoxyphenyl)prop-2-en-1-one
C18H17FO4
Acta Crystallographica Section E (2009) 65, 8 o1965-o1966
a=12.4250(2)Å b=8.62800(10)Å c=14.9038(2)Å
α=90.00° β=98.3217(12)° γ=90.00°
Di-μ-perchlorato-bis{μ-2-[(2-pyridyl)methylaminomethyl]phenolato)dicopper(II) acetonitrile disolvate
C26H26Cl2Cu2N4O10,2(C2H3N)
Acta Crystallographica Section E (2009) 65, 8 m1007-m1008
a=16.0285(4)Å b=9.4062(3)Å c=24.7097(10)Å
α=90.00° β=102.665(3)° γ=90.00°
6-{[(Benzyloxy)carbonyl]oxy}-2-methylhexahydropyrano[3,2-<i>d</i>][1,3]dioxin-7,8-diyl bis(chloroacetate)
C20H22Cl2O10
Acta Crystallographica Section E (2010) 66, 3 o572-o573
a=8.17800(10)Å b=14.9165(3)Å c=19.3555(4)Å
α=90.00° β=90.00° γ=90.00°
{3,3',5,5'-Tetramethoxy-2,2'-[ethane-1,2- diylbis(nitrilomethylidyne)]diphenolato}nickel(II)
C20H22N2NiO6
Acta Crystallographica Section E (2010) 66, 6 m620
a=7.41599(12)Å b=15.6945(2)Å c=15.7203(2)Å
α=90.00° β=91.9153(13)° γ=90.00°
Lansoprazole intermediate--chloranilic acid (2:1)
2(C16H15F3N3OS),C6Cl2O42
Acta Crystallographica Section E (2010) 66, 6 o1507-o1508
a=9.48575(8)Å b=23.6316(2)Å c=17.86775(15)Å
α=90.00° β=100.2065(9)° γ=90.00°
Aqua{6,6'-dimethoxy-2,2'-[ethane-1,2- diylbis(nitrilomethylidyne)]diphenolato}methanolmanganese(III)) perchlorate hemihydrate
C19H24MnN2O6,ClO4,0.5(H2O)
Acta Crystallographica Section E (2010) 66, 7 m851-m852
a=22.7438(15)Å b=13.3986(9)Å c=16.3266(10)Å
α=90.00° β=101.324(7)° γ=90.00°
Tris(ethane-1,2-diamine-κ^2^<i>N</i>,<i>N</i>)cobalt(III) carbonate iodide tetrahydrate
C6H24CoN63,CO3,I,4(H2O)
Acta Crystallographica Section E (2010) 66, 9 m1148-m1149
a=16.6907(2)Å b=8.70310(10)Å c=12.5718(2)Å
α=90.00° β=90.00° γ=90.00°
(1<i>E</i>,2<i>E</i>)-1,2-Bis(2,3,4-trimethoxybenzylidene)hydrazine
C20H24N2O6
Acta Crystallographica Section E (2010) 66, 10 o2557
a=10.0380(9)Å b=7.0713(7)Å c=13.9586(14)Å
α=90.00° β=102.800(2)° γ=90.00°
<i>catena</i>-Poly[[[{5,5-dimethoxy-2,2'-[ethane-1,2- diylbis(nitrilomethylidyne)]diphenolato}manganese(III)]-μ-acetato] methanol monosolvate]
C20H21MnN2O6,CH4O
Acta Crystallographica Section E (2010) 66, 11 m1384-m1385
a=6.6237(2)Å b=21.5007(6)Å c=14.5544(4)Å
α=90.00° β=97.539(3)° γ=90.00°
Tetra-μ~3~-methanolato-tetrakis[(2-formyl-6- methoxyphenolato)methanolnickel(II)]
C40H56Ni4O20
Acta Crystallographica Section E (2010) 66, 11 m1487-m1488
a=22.2670(9)Å b=22.2670(9)Å c=9.70106(10)Å
α=90.00° β=90.00° γ=90.00°
1H-imidazole
C25H16N4
Acta Crystallographica Section E (2011) 67, 4 o989
a=8.8693(7)Å b=10.0637(6)Å c=11.8960(9)Å
α=100.219(6)° β=110.310(7)° γ=102.475(6)°
(2<i>E</i>)-3-(2-Anthracen-2-yl)-1-(2-hydroxyphenyl)prop-2-en-1-one
C23H16O2
Acta Crystallographica Section E (2011) 67, 4 o795
a=14.0748(5)Å b=13.7362(5)Å c=16.9800(8)Å
α=90.00° β=101.487(5)° γ=90.00°
3,5-Bis(4-methylphenyl)-1-phenyl-4,5-dihydro-1<i>H</i>-pyrazole
C23H22N2
Acta Crystallographica Section E (2011) 67, 4 o1019
a=5.8113(3)Å b=10.6959(5)Å c=28.4455(13)Å
α=90° β=94.983(4)° γ=90°
Carbazole
C13H13NO
Acta Crystallographica Section E (2010) 66, 9 o2299-o2300
a=10.5245(2)Å b=7.15640(10)Å c=13.5870(3)Å
α=90° β=93.960(2)° γ=90°
(3aR,8aR)-2,2,6,6-Tetramethyl-4,4,8,8-tetraphenyltetrahydro-1,3- dioxolo[4,5-<i>e</i>][1,3,2]dioxasilepine
C33H34O4Si
Acta Crystallographica Section E (2009) 65, 1 o135
a=10.008(2)Å b=17.081(3)Å c=17.271(3)Å
α=90.00° β=90.00° γ=90.00°
<i>N</i>,<i>N</i>'-Bis[(<i>E</i>)-2-fluorobenzylidene]-1-(2- fluorophenyl)methanediamine
C21H15F3N2
Acta Crystallographica Section E (2010) 66, 2 o422-o423
a=8.0215(5)Å b=9.3740(4)Å c=11.9744(6)Å
α=99.184(4)° β=93.179(5)° γ=108.165(5)°
Carbazole
C15H13NO2
Acta Crystallographica Section E (2010) 66, 12 o3146
a=7.4602(2)Å b=12.7353(3)Å c=24.9325(5)Å
α=90° β=92.319(2)° γ=90°
<i>tert</i>-Butyl 6-methyl-2-oxo-4-[4-(trifluoromethoxy)anilino]cyclohex-3-ene-1-carboxylate
C19H22F3NO4
Acta Crystallographica Section E (2010) 66, 12 o3229
a=13.7896(3)Å b=12.0820(2)Å c=11.0023(2)Å
α=90.00° β=91.1978(18)° γ=90.00°
1-(4-Bromophenyl)-3-butanoylthiourea
C11H13BrN2OS
Acta Crystallographica Section E (2011) 67, 1 o46
a=6.1746(3)Å b=10.7883(4)Å c=19.6450(8)Å
α=87.719(3)° β=81.557(4)° γ=76.047(4)°
3-(4-Chlorophenyl)-1-(2-methyl-4-phenylquinolin-3-yl)prop-2-en-1-one
C25H18ClNO
Acta Crystallographica Section E (2011) 67, 3 o621
a=6.5376(2)Å b=10.0345(4)Å c=15.6545(6)Å
α=90.845(3)° β=95.521(3)° γ=107.035(3)°
Bis[2-(benzylamino)pyridine-κ<i>N</i>^1^]bis(2-formylphenolato- κ^2^<i>O</i>,<i>O</i>)nickel(II)
C38H34N4NiO4
Acta Crystallographica Section E (2011) 67, 2 m207-m208
a=8.1747(5)Å b=9.3365(5)Å c=10.9183(6)Å
α=73.926(5)° β=84.766(5)° γ=77.247(5)°
1-(5-Carboxypentyl)-2,3,3-trimethyl-3<i>H</i>-indol-1-ium bromide monohydrate
C17H24NO2,Br,H2O
Acta Crystallographica Section E (2010) 66, 1 o171-o172
a=14.4528(3)Å b=15.3367(2)Å c=8.0810(2)Å
α=90.00° β=99.437(2)° γ=90.00°
2,4-Dichloro-1-[1-(2,4-dichlorobenzyloxy)ethyl]benzene
C15H12Cl4O
Acta Crystallographica Section E (2010) 66, 1 o165-o166
a=9.3755(4)Å b=9.9229(4)Å c=9.9667(4)Å
α=62.313(3)° β=70.246(4)° γ=71.467(4)°
Desipramine hydrochloride
C18H23N2,Cl
Acta Crystallographica Section E (2010) 66, 3 o674-o675
a=10.7258(3)Å b=15.9997(6)Å c=20.6088(8)Å
α=107.347(3)° β=89.960(2)° γ=99.414(2)°
(2<i>E</i>)-1-(2-Bromophenyl)-3-(4-bromophenyl)prop-2-en-1-one
C15H10Br2O
Acta Crystallographica Section E (2010) 66, 7 o1701
a=5.6988(5)Å b=9.5462(9)Å c=23.8532(15)Å
α=90.00° β=91.021(8)° γ=90.00°
Carbazole
C15H11N3
Acta Crystallographica Section E (2010) 66, 7 o1713
a=8.4794(3)Å b=10.5542(4)Å c=13.0575(5)Å
α=90° β=97.366(3)° γ=90°
(2<i>E</i>)-1-(2-Bromophenyl)-3-(3,4,5-trimethoxyphenyl)prop-2-en-1-one
C18H17BrO4
Acta Crystallographica Section E (2010) 66, 7 o1676
a=9.9616(4)Å b=13.6020(13)Å c=24.4162(17)Å
α=90.00° β=90.00° γ=90.00°
1-Nonyl-1<i>H</i>-benzimidazol-2(3<i>H</i>)-one
C16H24N2O
Acta Crystallographica Section E (2011) 67, 2 o283
a=18.0230(10)Å b=5.4585(2)Å c=16.5708(9)Å
α=90.00° β=115.543(7)° γ=90.00°
Cinnarizinium dipicrate
C26H30N22,2(C6H2N3O7)
Acta Crystallographica Section E (2011) 67, 2 o500-o501
a=15.1987(2)Å b=10.09130(17)Å c=25.0724(3)Å
α=90.00° β=95.9170(14)° γ=90.00°
(<i>RS</i>)-4-(3-carboxy-1-ethyl-6,8-difluoro-4-oxo-1,4-dihydroquinolin-7-yl)- 2-methylpiperazin-1-ium 2,4,6-trinitrophenolate
C17H20F2N3O3,C6H2N3O7
Acta Crystallographica Section E (2011) 67, 2 o483-o484
a=10.9314(4)Å b=11.6748(4)Å c=12.0530(4)Å
α=92.969(3)° β=115.555(3)° γ=109.852(3)°
Ethyl 2-(4-nitrobenzamido)benzoate
C16H14N2O5
Acta Crystallographica Section E (2011) 67, 2 o465
a=6.9802(3)Å b=9.3570(4)Å c=12.5779(5)Å
α=102.833(4)° β=94.296(4)° γ=107.567(4)°
Di-μ~2~-acetato-diacetato-bis{μ~2~-3,3,5,5'-tetramethoxy-2,2-[ethane-1,2- diylbis(nitrilomethylidyne)]diphenolato}tricobalt(II,III) dichloromethane disolvate
C48H56Co3N4O20,2(CH2Cl2)
Acta Crystallographica Section E (2011) 67, 3 m303-m304
a=13.9235(9)Å b=13.4407(8)Å c=16.0019(11)Å
α=90.00° β=112.724(8)° γ=90.00°
Piperidin-4-one
C22H19NOS2
Acta Crystallographica Section E (2011) 67, 3 o571
a=6.1809(3)Å b=12.7391(9)Å c=12.9251(7)Å
α=112.657(6)° β=95.845(5)° γ=98.512(5)°
2,5-Dimethyl-3-[4-(trifluoromethoxy)anilino]cyclohex-2-enone
C15H16F3NO2
Acta Crystallographica Section E (2011) 67, 3 o603-o604
a=6.10302(11)Å b=8.39246(16)Å c=28.2487(5)Å
α=90.00° β=93.6941(16)° γ=90.00°
Ethylenediammonium dipicrate dihydrate
C2H10N22,2(C6H2N3O7),2(H2O)
Acta Crystallographica Section E (2011) 67, 3 o637-o638
a=13.4795(4)Å b=20.4372(7)Å c=8.0410(3)Å
α=90.00° β=90.00° γ=90.00°
Piperidin-4-one
C21H25NO
Acta Crystallographica Section E (2009) 65, 10 o2445
a=12.9576(3)Å b=22.6153(5)Å c=5.96000(10)Å
α=90° β=90° γ=90°
4-[(<i>E</i>)-(2,4-Difluorophenyl)(hydroxyimino)methyl]piperidinium picrate
C12H15F2N2O,C6H2N3O7
Acta Crystallographica Section E (2009) 65, 10 o2365-o2366
a=6.0926(4)Å b=13.5364(8)Å c=24.0417(14)Å
α=90.00° β=92.671(6)° γ=90.00°
Pyrazoline
C16H13Cl2FN2OS
Acta Crystallographica Section E (2008) 64, 11 o2160
a=7.2240(5)Å b=8.8642(4)Å c=14.0518(9)Å
α=100.794(5)° β=103.307(6)° γ=101.003(5)°
4-[5-Methyl-4-(morpholin-4-ylcarbonyl)-1<i>H</i>-1,2,3-triazol-1-yl]- 8-(trifluoromethyl)quinoline
C18H16F3N5O2
Acta Crystallographica Section E (2008) 64, 12 o2375
a=9.2836(15)Å b=9.6164(11)Å c=9.9272(11)Å
α=92.082(9)° β=93.063(11)° γ=105.728(12)°
Dihydropyrimidinone
C13H13ClN2O2
Acta Crystallographica Section E (2008) 64, 12 o2474-o2475
a=14.5364(8)Å b=12.1587(5)Å c=7.0780(4)Å
α=90° β=90° γ=90°
Piperidin-4-one
C21H25NO3
Acta Crystallographica Section E (2008) 64, 12 o2328
a=5.9772(2)Å b=23.0858(8)Å c=26.7611(8)Å
α=90° β=93.543(3)° γ=90°
Triphenylpyrazine
C22H16N2
Acta Crystallographica Section E (2009) 65, 1 o106
a=15.563(2)Å b=6.2005(9)Å c=16.845(3)Å
α=90° β=90° γ=90°
<i>N</i>-(3-Bromo-1,4-dioxo-1,4-dihydro-2-naphthyl)-4-fluoro-<i>N</i>- (4-fluorobenzoyl)benzamide
C24H12BrF2NO4
Acta Crystallographica Section E (2009) 65, 2 o277
a=14.5931(3)Å b=6.64710(10)Å c=20.6324(4)Å
α=90.00° β=98.407(2)° γ=90.00°
3-(2,6-Dioxopiperidin-3-yl)-3-azabicyclo[3.2.0]heptane-2,4-dione
C11H12N2O4
Acta Crystallographica Section E (2009) 65, 2 o394-o395
a=10.7332(7)Å b=9.9358(5)Å c=11.0753(7)Å
α=90.00° β=116.201(8)° γ=90.00°
(<i>E</i>)-2-[(2-Hydroxy-5-nitrophenyl)iminiomethyl]-4-nitrophenolate
C13H9N3O6
Acta Crystallographica Section E (2009) 65, 2 o291-o292
a=7.96490(10)Å b=8.61100(10)Å c=19.1190(3)Å
α=90.00° β=98.433(2)° γ=90.00°
(<i>E</i>)-2-{(2-Hydroxynaphthalen-1-yl)methylene}hydrazinecarboxamide
C12H11N3O2
Acta Crystallographica Section E (2009) 65, 5 o1111-o1112
a=16.0886(4)Å b=4.72900(10)Å c=15.6452(4)Å
α=90.00° β=114.647(3)° γ=90.00°
Nicotinohydrazide
C16H15N3O,H2O
Acta Crystallographica Section E (2009) 65, 7 o1659
a=9.6821(4)Å b=9.4178(4)Å c=16.0958(6)Å
α=90° β=98.250(4)° γ=90°
4-(2,2-Diphenyl-2-propoxyacetoxy)-1-methylpiperidin-1-ium picrate
C23H30NO3,C6H2N3O7
Acta Crystallographica Section E (2009) 65, 8 o1738-o1739
a=8.9379(4)Å b=9.2885(4)Å c=18.0750(7)Å
α=97.652(3)° β=97.630(3)° γ=104.301(4)°
Carbazolone
C13H13NO
Acta Crystallographica Section E (2009) 65, 8 o1946-o1947
a=5.8301(3)Å b=8.4348(5)Å c=10.8000(7)Å
α=78.094(5)° β=75.942(5)° γ=87.166(5)°
3-(2-Chloroethyl)-2-methyl-4<i>H</i>-pyrido[1,2-<i>a</i>] pyrimidinium-4-one picrate
C11H12ClN2O,C6H2N3O7
Acta Crystallographica Section E (2009) 65, 9 o2201-o2202
a=7.2718(5)Å b=12.8159(9)Å c=19.940(3)Å
α=90.00° β=97.642(9)° γ=90.00°
Bis[μ-2-(2-pyridylmethylaminomethyl)phenolato]- κ^4^<i>N</i>,<i>N</i>,<i>O</i>:<i>O</i>; κ^4^<i>O</i>:<i>N</i>,<i>N</i>',<i>O</i>-bis[(thiocyanato- κ<i>N</i>)copper(II)]
C28H26Cu2N6O2S2
Acta Crystallographica Section E (2009) 65, 9 m1121-m1122
a=7.47470(10)Å b=16.9237(3)Å c=11.0714(2)Å
α=90.00° β=91.1317(18)° γ=90.00°
Haloperidol picrate
C21H24ClFNO2,C6H2N3O7
Acta Crystallographica Section E (2009) 65, 10 o2403-o2404
a=14.9089(5)Å b=12.5934(3)Å c=14.5074(5)Å
α=90.00° β=90.00° γ=90.00°
Bis[2-(benzylamino)pyridine-κ<i>N</i>](2-formyl-6-methoxyphenolato- κ^2^<i>O</i>^1^,<i>O</i>^6^)(nitrato-κ^2^<i>O</i>,<i>O</i>)nickel(II)
C32H31N5NiO6
Acta Crystallographica Section E (2009) 65, 10 m1193-m1194
a=10.3522(2)Å b=16.7539(3)Å c=16.8132(3)Å
α=90.00° β=95.5831(17)° γ=90.00°
<i>N</i>-(2-Bromobenzyl)-<i>N</i>'-(2-pyridyl)benzene-1,2-diamine
C18H16BrN3
Acta Crystallographica Section E (2009) 65, 11 o2640
a=7.9429(5)Å b=9.5314(8)Å c=11.0606(8)Å
α=98.741(6)° β=90.727(6)° γ=103.581(6)°
1-(2-methyl-5-nitrophenyl)guanidinium picrate
C8H11N4O2,C6H2N3O7
Acta Crystallographica Section E (2009) 65, 11 o2788-o2789
a=7.1318(10)Å b=10.6239(13)Å c=11.9564(13)Å
α=84.257(10)° β=74.497(11)° γ=77.559(11)°
Piperidin-4-one
C21H23NO4
Acta Crystallographica Section E (2009) 65, 11 o2813
a=11.5409(4)Å b=12.4972(5)Å c=14.7816(6)Å
α=67.878(4)° β=74.719(3)° γ=67.123(4)°
1-(2-Bromobenzyl)-3-isopropylbenzimidazolin-2-one
C17H17BrN2O
Acta Crystallographica Section E (2009) 65, 11 o2836
a=12.1417(3)Å b=10.1146(3)Å c=12.2008(3)Å
α=90.00° β=95.7630(10)° γ=90.00°
2-Bromo-3-nitrobenzaldehyde
C7H4BrNO3
Acta Crystallographica Section E (2009) 65, 11 o2761
a=8.1578(8)Å b=6.3079(5)Å c=15.0537(11)Å
α=90.00° β=91.603(8)° γ=90.00°
1,4-diphenylbutadienylcyanide
C17H13N
Acta Crystallographica Section E (2009) 65, 11 o2953
a=16.9390(5)Å b=7.5869(2)Å c=19.3809(6)Å
α=90° β=99.521(3)° γ=90°
(2<i>E</i>)-1-(3-Chlorophenyl)-3-(4-chlorophenyl)prop-2-en-1-one
C15H10Cl2O
Acta Crystallographica Section E (2009) 65, 11 o2641-o2642
a=5.8884(9)Å b=7.3328(9)Å c=14.6752(16)Å
α=102.821(10)° β=95.003(10)° γ=92.933(11)°
(2<i>E</i>)-3-(4-Bromophenyl)-1-(3-chlorophenyl)prop-2-en-1-one
C15H10BrClO
Acta Crystallographica Section E (2010) 66, 1 o158
a=5.9197(8)Å b=7.3391(11)Å c=14.8171(17)Å
α=101.929(11)° β=94.371(10)° γ=93.299(11)°
<i>N</i>-(3,4-Dichlorophenyl)-3-oxobutanamide
C10H9Cl2NO2
Acta Crystallographica Section E (2010) 66, 1 o58-o59
a=9.7171(4)Å b=8.2834(5)Å c=27.4857(16)Å
α=90.00° β=90.00° γ=90.00°
6,11-Dihydrodibenz[<i>b</i>,<i>e</i>]oxepin-11-one
C14H10O2
Acta Crystallographica Section E (2010) 66, 1 o159-o160
a=16.5065(18)Å b=4.0806(7)Å c=15.0392(17)Å
α=90.00° β=93.654(10)° γ=90.00°
Gabapentin-lactum--chloranilic acid (1/1)
C9H15NO,C6H2Cl2O4
Acta Crystallographica Section E (2010) 66, 1 o163-o164
a=6.6127(9)Å b=9.5800(11)Å c=13.0724(13)Å
α=102.679(9)° β=91.934(9)° γ=98.481(10)°